Prostate cancer: should PSA screening be routine?

September 3, 2014 1:24 PM

14 0

Last updated: Today at 8am PST

The US Food And Drug Administration (FDA) first approved prostate-specific antigen (PSA) testing to screen asymptomatic men for prostate cancer in the early 1990s. In the decade prior to this approval, 5-year survival rates from the cancer stood at around 70-75%. By 1998, it had increased to 98.2%.

Read more

To category page